phenytoin has been researched along with Central Nervous System Cysticercosis in 18 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the response to albendazole treatment in patients who had SSECTL and new onset seizures treated with antiepileptic drugs (AED) in a prospective clinical trial." | 9.13 | Albendazole therapy for single small enhancing CT lesions (SSECTL) in the brain in epilepsy. ( Chattopadhyay, A; Khandelwal, N; Sawhney, IM; Thussu, A, 2008) |
| "To determine the safety and efficacy (measured by the incidence of 'treatment failure') of clobazam in comparison to standard treatment with phenytoin-sodium for prevention of seizures in persons with solitary cysticercus granulomas (SCGs)." | 9.12 | Safety and efficacy of clobazam versus phenytoin-sodium in the antiepileptic drug treatment of solitary cysticercus granulomas. ( Chopra, SC; Kaushal, S; Rani, A; Singh, G, 2006) |
| "Albendazole plus dexamethasone increased complete or partial resolution of lesions and reduced the risk of subsequent recurrence of seizures among children with neurocysticercosis who had with seizures and 1 or 2 ring-enhancing lesions on computed tomography." | 9.10 | Efficacy of albendazole and short-course dexamethasone treatment in children with 1 or 2 ring-enhancing lesions of neurocysticercosis: a randomized controlled trial. ( Dua, T; Kalra, V; Kumar, V, 2003) |
| " The pharmacokinetic parameters were analyzed by analysis of variance followed by the Tukey-Kramer test." | 6.70 | Pharmacokinetic interaction between albendazole sulfoxide enantiomers and antiepileptic drugs in patients with neurocysticercosis. ( Dreossi, SA; Garcia, FS; Lanchote, VL; Takayanagui, OM, 2002) |
| "To evaluate the response to albendazole treatment in patients who had SSECTL and new onset seizures treated with antiepileptic drugs (AED) in a prospective clinical trial." | 5.13 | Albendazole therapy for single small enhancing CT lesions (SSECTL) in the brain in epilepsy. ( Chattopadhyay, A; Khandelwal, N; Sawhney, IM; Thussu, A, 2008) |
| "To determine the safety and efficacy (measured by the incidence of 'treatment failure') of clobazam in comparison to standard treatment with phenytoin-sodium for prevention of seizures in persons with solitary cysticercus granulomas (SCGs)." | 5.12 | Safety and efficacy of clobazam versus phenytoin-sodium in the antiepileptic drug treatment of solitary cysticercus granulomas. ( Chopra, SC; Kaushal, S; Rani, A; Singh, G, 2006) |
| "Albendazole plus dexamethasone increased complete or partial resolution of lesions and reduced the risk of subsequent recurrence of seizures among children with neurocysticercosis who had with seizures and 1 or 2 ring-enhancing lesions on computed tomography." | 5.10 | Efficacy of albendazole and short-course dexamethasone treatment in children with 1 or 2 ring-enhancing lesions of neurocysticercosis: a randomized controlled trial. ( Dua, T; Kalra, V; Kumar, V, 2003) |
| " Carbamazepine or oxcarbazepine are best suited for seizure prophylaxis for those who present with seizures; phenytoin and levetiracetam are the other alternatives." | 4.02 | Management of Neurocysticercosis in Children: Association of Child Neurology Consensus Guidelines. ( Kadwa, RA; Kamate, M; Kannan, L; Kumar, A; Passi, GR; Sankhyan, N; Sharawat, IK; Singhi, P, 2021) |
| " The aim of this study was to study the frequency and nature of cutaneous reactions in a cohort of patients being treated with phenytoin sodium for seizures, who were divided into those with a solitary cysticercus granuloma (SCG) and those with a condition other than SCG, to determine if the presence of SCG increases the risk of cutaneous adverse reaction to phenytoin." | 3.72 | Cutaneous reactions in patients with solitary cysticercus granuloma on phenytoin sodium. ( Chander Chopra, S; Gupta, M; Kaushal, S; Singh, G, 2004) |
| " The pharmacokinetic parameters were analyzed by analysis of variance followed by the Tukey-Kramer test." | 2.70 | Pharmacokinetic interaction between albendazole sulfoxide enantiomers and antiepileptic drugs in patients with neurocysticercosis. ( Dreossi, SA; Garcia, FS; Lanchote, VL; Takayanagui, OM, 2002) |
| "Epilepsy is the commonest clinical presentation, though it may also present with headache, symptoms of raised intracranial tension, hydrocephalus and ocular symptoms depending upon the localisation of the parasitic cysts." | 2.52 | Antiepileptic drugs for seizure control in people with neurocysticercosis. ( Mathew, A; Sharma, M; Singh, T, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.56) | 18.2507 |
| 2000's | 11 (61.11) | 29.6817 |
| 2010's | 5 (27.78) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Sankhyan, N | 1 |
| Kadwa, RA | 1 |
| Kamate, M | 1 |
| Kannan, L | 1 |
| Kumar, A | 1 |
| Passi, GR | 1 |
| Sharawat, IK | 1 |
| Singhi, P | 1 |
| Khemka, P | 1 |
| Ray, S | 1 |
| Mukherjee, D | 1 |
| Sharma, M | 1 |
| Singh, T | 1 |
| Mathew, A | 1 |
| Tan, TC | 1 |
| de Boer, BW | 1 |
| Mitchell, A | 1 |
| Delriviere, L | 1 |
| Adams, LA | 1 |
| Jeffrey, GP | 1 |
| Macquillan, G | 1 |
| Burneo, JG | 1 |
| Plener, I | 1 |
| Garcia, HH | 1 |
| Sohrabi, F | 1 |
| Kaushal, S | 3 |
| Sharma, A | 1 |
| Singh, B | 1 |
| Kumar, V | 2 |
| Sharma, V | 1 |
| Sanjay, S | 1 |
| Koh, YT | 1 |
| Gan, NY | 1 |
| Vishnu, VY | 1 |
| Kesav, P | 1 |
| Prabhakar, S | 1 |
| Kalra, V | 1 |
| Dua, T | 1 |
| Singh, G | 2 |
| Gupta, M | 1 |
| Chander Chopra, S | 1 |
| Bowie, EM | 1 |
| Folk, JC | 1 |
| Barnes, CH | 1 |
| Menon, B | 1 |
| Arasu, K | 1 |
| Khairul, A | 1 |
| Waran, V | 1 |
| Rani, A | 1 |
| Chopra, SC | 1 |
| Thussu, A | 1 |
| Chattopadhyay, A | 1 |
| Sawhney, IM | 1 |
| Khandelwal, N | 1 |
| Yoo, JH | 1 |
| Kang, DS | 1 |
| Chun, WH | 1 |
| Lee, WJ | 1 |
| Lee, AK | 1 |
| Lanchote, VL | 1 |
| Garcia, FS | 1 |
| Dreossi, SA | 1 |
| Takayanagui, OM | 1 |
1 review available for phenytoin and Central Nervous System Cysticercosis
| Article | Year |
|---|---|
Antiepileptic drugs for seizure control in people with neurocysticercosis.
Topics: Adolescent; Adult; Anticonvulsants; Brain Diseases; Carbamazepine; Child; Child, Preschool; Epilepsy | 2015 |
4 trials available for phenytoin and Central Nervous System Cysticercosis
| Article | Year |
|---|---|
Efficacy of albendazole and short-course dexamethasone treatment in children with 1 or 2 ring-enhancing lesions of neurocysticercosis: a randomized controlled trial.
Topics: Adolescent; Albendazole; Anthelmintics; Anti-Inflammatory Agents; Anticonvulsants; Brain; Brain Edem | 2003 |
Safety and efficacy of clobazam versus phenytoin-sodium in the antiepileptic drug treatment of solitary cysticercus granulomas.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Benzodiazepines; Child, Preschool; Clobazam; Double-Blind | 2006 |
Albendazole therapy for single small enhancing CT lesions (SSECTL) in the brain in epilepsy.
Topics: Adolescent; Adult; Albendazole; Anthelmintics; Carbamazepine; Cerebral Cortex; Child; Child, Prescho | 2008 |
Pharmacokinetic interaction between albendazole sulfoxide enantiomers and antiepileptic drugs in patients with neurocysticercosis.
Topics: Adult; Albendazole; Anthelmintics; Anticonvulsants; Area Under Curve; Carbamazepine; Chromatography, | 2002 |
13 other studies available for phenytoin and Central Nervous System Cysticercosis
| Article | Year |
|---|---|
Management of Neurocysticercosis in Children: Association of Child Neurology Consensus Guidelines.
Topics: Albendazole; Child; Humans; Neurocysticercosis; Neurology; Phenytoin; Seizures | 2021 |
An unusual case of encephalitis with starry sky pattern in MRI.
Topics: Anticonvulsants; Antiparasitic Agents; Brain; Child, Preschool; Diagnosis, Differential; Disease Man | 2015 |
Levetiracetam as a possible cause of fulminant liver failure.
Topics: Adult; Anticonvulsants; Brain; Epilepsy; Humans; Levetiracetam; Liver; Liver Failure, Acute; Liver F | 2008 |
Neurocysticercosis in a patient in Canada.
Topics: Albendazole; Anti-Inflammatory Agents; Anticonvulsants; Antiprotozoal Agents; Brain; Brain Diseases; | 2009 |
Headache as the initial manifestation of neurocysticercosis: a case of eosinophilic meningitis.
Topics: Adult; Albendazole; Antibodies; Brain; Calcinosis; Dexamethasone; Eosinophilia; Headache; Humans; Im | 2009 |
Stars in the sky: neurocysticercosis.
Topics: Adult; Albendazole; Anthelmintics; Anticonvulsants; Diagnosis, Differential; Diuretics, Osmotic; Dru | 2012 |
A persistent red eye and diplopia--when to neuroimage?
Topics: Adult; Albendazole; Anthelmintics; Anticonvulsants; Dexamethasone; Diplopia; Female; Glucocorticoids | 2012 |
Disseminated cysticercosis.
Topics: Anticonvulsants; Cysticercosis; Drug Therapy, Combination; Glucocorticoids; Humans; Magnetic Resonan | 2013 |
Cutaneous reactions in patients with solitary cysticercus granuloma on phenytoin sodium.
Topics: Adult; Anticonvulsants; Drug Hypersensitivity; Exanthema; Female; Granuloma, Foreign-Body; Humans; M | 2004 |
Corticosteroids, central serous chorioretinopathy, and neurocysticercosis.
Topics: Adult; Albendazole; Anticonvulsants; Antiprotozoal Agents; Body Fluids; Combined Modality Therapy; D | 2004 |
Starry sky and beaded legs.
Topics: Adult; Albendazole; Anticestodal Agents; Anticonvulsants; Brain; Calcinosis; Female; Headache; Human | 2006 |
Neurocysticercosis an uncommon intra-cerebral infection in Malaysia.
Topics: Adult; Albendazole; Anthelmintics; Child; Female; Humans; Magnetic Resonance Imaging; Malaysia; Male | 2005 |
Anticonvulsant hypersensitivity syndrome with an epoxide hydrolase defect.
Topics: Anticonvulsants; Drug Hypersensitivity; Epilepsy; Humans; Male; Middle Aged; Neurocysticercosis; Phe | 1999 |